These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30688386)
1. Multiple ICD shocks in a patient with dilated cardiomyopathy: What is the mechanism? Fontenla A; López-Gil M; Rodríguez Muñoz D; Díez de Las Heras D; Arribas F J Cardiovasc Electrophysiol; 2019 May; 30(5):781-784. PubMed ID: 30688386 [TBL] [Abstract][Full Text] [Related]
2. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism? Vollmann D; Lüthje L; Zabel M Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370 [No Abstract] [Full Text] [Related]
3. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy. Strohmer B; Schernthaner C; Pichler M Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515 [TBL] [Abstract][Full Text] [Related]
4. Electrical storm in a patient with dilated non-ischaemic cardiomyopathy. De Meyer G; Van Beeumen K; Duytschaever M Acta Cardiol; 2009 Oct; 64(5):681-5. PubMed ID: 20058518 [TBL] [Abstract][Full Text] [Related]
5. Recurrent AICD shocks in a 60-year-old man. Yeo C; Wong KC Heart; 2016 Aug; 102(16):1295. PubMed ID: 26980721 [TBL] [Abstract][Full Text] [Related]
6. Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator. Takahashi A; Shiga T; Shoda M; Tanizaki K; Manaka T; Ejima K; Kasanuki H; Hagiwara N Heart Vessels; 2010 Mar; 25(2):150-4. PubMed ID: 20339977 [TBL] [Abstract][Full Text] [Related]
7. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism? Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856 [No Abstract] [Full Text] [Related]
8. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator. Chinushi M; Aizawa Y; Higuchi K Heart; 1997 Apr; 77(4):373-4. PubMed ID: 9155621 [TBL] [Abstract][Full Text] [Related]
9. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy. Naruse Y; Nogami A; Shinoda Y; Hanaki Y; Shirai Y; Kowase S; Kurosaki K; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399 [TBL] [Abstract][Full Text] [Related]
10. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
11. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention. Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305 [TBL] [Abstract][Full Text] [Related]
14. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
15. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy. Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259 [TBL] [Abstract][Full Text] [Related]
16. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing. Jackson N; Viswanathan K; Cameron D; Nair K Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146 [No Abstract] [Full Text] [Related]
17. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical ventricular activation sequence and ParaHisian entrainment response: do they challenge the diagnosis? Nayyar S; Young GD; Sanders P; Roberts-Thomson KC Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):e1-6. PubMed ID: 23424225 [No Abstract] [Full Text] [Related]
19. Use of "IEGM Online" in ICD patients--early detection of inappropriate classified ventricular tachycardia via home monitoring. Ritter O; Bauer WR Clin Res Cardiol; 2006 Jul; 95(7):368-72. PubMed ID: 16773280 [No Abstract] [Full Text] [Related]
20. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device. Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]